NZ226089A - Pyrimidinylamino derivatives of substituted piperidine; pharmaceutical compositions and processes of preparation - Google Patents

Pyrimidinylamino derivatives of substituted piperidine; pharmaceutical compositions and processes of preparation

Info

Publication number
NZ226089A
NZ226089A NZ226089A NZ22608988A NZ226089A NZ 226089 A NZ226089 A NZ 226089A NZ 226089 A NZ226089 A NZ 226089A NZ 22608988 A NZ22608988 A NZ 22608988A NZ 226089 A NZ226089 A NZ 226089A
Authority
NZ
New Zealand
Prior art keywords
compound
formula
group
hydrogen
mixture
Prior art date
Application number
NZ226089A
Other languages
English (en)
Inventor
Philippe Manoury
Alfred Saarmets
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NZ226089A publication Critical patent/NZ226089A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
NZ226089A 1987-09-09 1988-09-08 Pyrimidinylamino derivatives of substituted piperidine; pharmaceutical compositions and processes of preparation NZ226089A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8712502A FR2620121B1 (fr) 1987-09-09 1987-09-09 ((pyrimidinyl-2)-aminoalkyl)-1 piperidines, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
NZ226089A true NZ226089A (en) 1990-06-26

Family

ID=9354744

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ226089A NZ226089A (en) 1987-09-09 1988-09-08 Pyrimidinylamino derivatives of substituted piperidine; pharmaceutical compositions and processes of preparation

Country Status (18)

Country Link
US (2) US4891376A (no)
EP (1) EP0307303B1 (no)
JP (1) JPH01104069A (no)
KR (1) KR890005086A (no)
AT (1) ATE70062T1 (no)
AU (1) AU603004B2 (no)
DE (1) DE3866646D1 (no)
DK (1) DK499088A (no)
ES (1) ES2040879T3 (no)
FI (1) FI884132A (no)
FR (1) FR2620121B1 (no)
GR (1) GR3003481T3 (no)
HU (1) HU199141B (no)
IL (1) IL87609A (no)
NO (1) NO883994L (no)
NZ (1) NZ226089A (no)
PT (1) PT88460B (no)
ZA (1) ZA886698B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2618436B1 (fr) * 1987-07-23 1989-10-27 Synthelabo Derives de piperidine, leur preparation et leur application en therapeutique
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
US5231104A (en) * 1988-07-08 1993-07-27 Pfizer Inc. 1-arylethyl-3-substituted piperidines
FR2678271B1 (fr) * 1991-06-27 1995-01-13 Synthelabo Derives de pyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
KR100351012B1 (ko) * 1994-04-20 2002-12-26 아지노모토 가부시키가이샤 피페리딘유도체및이를함유하는항혈소판제
JP3779349B2 (ja) * 1995-04-24 2006-05-24 興和株式会社 ピペリジン誘導体
JP2914324B2 (ja) 1995-10-23 1999-06-28 味の素株式会社 ピペリジン誘導体の結晶並びにその製造中間体及び製造方法
US5869497A (en) * 1996-03-15 1999-02-09 Eli Lilly And Company Method of treating or ameliorating the symptoms of common cold or allergic rhinitis
US7941675B2 (en) * 2002-12-31 2011-05-10 Burr James B Adaptive power control
US7112978B1 (en) 2002-04-16 2006-09-26 Transmeta Corporation Frequency specific closed loop feedback control of integrated circuits
US7949864B1 (en) * 2002-12-31 2011-05-24 Vjekoslav Svilan Balanced adaptive body bias control
US7228242B2 (en) 2002-12-31 2007-06-05 Transmeta Corporation Adaptive power control based on pre package characterization of integrated circuits
US7953990B2 (en) * 2002-12-31 2011-05-31 Stewart Thomas E Adaptive power control based on post package characterization of integrated circuits
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
US7129771B1 (en) 2003-12-23 2006-10-31 Transmeta Corporation Servo loop for well bias voltage source
US7692477B1 (en) 2003-12-23 2010-04-06 Tien-Min Chen Precise control component for a substrate potential regulation circuit
US7012461B1 (en) 2003-12-23 2006-03-14 Transmeta Corporation Stabilization component for a substrate potential regulation circuit
US7649402B1 (en) * 2003-12-23 2010-01-19 Tien-Min Chen Feedback-controlled body-bias voltage source
US7774625B1 (en) 2004-06-22 2010-08-10 Eric Chien-Li Sheng Adaptive voltage control by accessing information stored within and specific to a microprocessor
MX2010008400A (es) * 2008-01-30 2010-08-23 Nippon Zoki Pharmaceutical Co Derivado de piperidina.
JP5083989B2 (ja) * 2008-11-20 2012-11-28 日本臓器製薬株式会社 ピペリジン誘導体を含有する医薬
US9296731B2 (en) * 2011-06-28 2016-03-29 Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd. Anti-allergy benzocycloheptathiophene derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254127A (en) * 1980-04-03 1981-03-03 Janssen Pharmaceutica, N.V. 1,3-Dihydro-1-[(1-piperidinyl)alkyl]-2H-benzimidazol-2-one derivatives

Also Published As

Publication number Publication date
DE3866646D1 (de) 1992-01-16
EP0307303A1 (fr) 1989-03-15
DK499088A (da) 1989-04-03
US4929621A (en) 1990-05-29
NO883994L (no) 1989-03-10
NO883994D0 (no) 1988-09-08
JPH01104069A (ja) 1989-04-21
FR2620121B1 (fr) 1990-01-05
FI884132A (fi) 1989-03-10
FR2620121A1 (fr) 1989-03-10
GR3003481T3 (en) 1993-02-17
AU2201088A (en) 1989-03-23
DK499088D0 (da) 1988-09-08
ZA886698B (en) 1989-04-26
IL87609A (en) 1992-09-06
EP0307303B1 (fr) 1991-12-04
PT88460B (pt) 1992-11-30
US4891376A (en) 1990-01-02
PT88460A (pt) 1988-10-01
FI884132A0 (fi) 1988-09-08
KR890005086A (ko) 1989-05-11
AU603004B2 (en) 1990-11-01
ATE70062T1 (de) 1991-12-15
HUT47927A (en) 1989-04-28
IL87609A0 (en) 1989-01-31
ES2040879T3 (es) 1993-11-01
HU199141B (en) 1990-01-29

Similar Documents

Publication Publication Date Title
NZ226089A (en) Pyrimidinylamino derivatives of substituted piperidine; pharmaceutical compositions and processes of preparation
RU2067975C1 (ru) 1,2-дигидро-2-оксопиридины, их физиологически приемлемые соли и фармацевтическая композиция
CA1290756C (en) Quinazolinone derivative and processes for preparing the same
JP3447292B2 (ja) イミダゾピリジン及び胃腸の疾病の治療のためのその使用
JPS6049192B2 (ja) 新規置換ベンズアミド、その製造方法及びこれを有効成分とする向精神薬
AU648394B2 (en) 4-aryl-thiazole or imidazole derivatives
JPH0649027A (ja) インドール誘導体
CZ179598A3 (cs) Nové metody a použití
IE57713B1 (en) New xanthine derivatives,processes for their preparation and pharmaceutical compositions containing them
JPH0794455B2 (ja) 双性イオン性二環式化合物およびその塩、溶媒和物、水和物ならびにエステル
US4264613A (en) Piperidylbenzimidazolinone compounds
NZ272687A (en) 1,3-dioxo-6-(3-aminopropyl)-1,2,3,6-tetrahydro-4-heteroaryl- pyrrolo[3,4-c]carbazoles derivatives
AU600378B2 (en) Piperidine derivatives, their preparation and their application in therapy
KR950006891B1 (ko) 아미노 알코올의 제조방법
US4628055A (en) Method for treating allergic reactions and compositions therefore
WO2001002386A1 (en) SELECTIVE M2 MUSCARINIC RECEPTOR ANTAGONISTS HAVING 5H-DIBENZ[b,f]AZEPINE STRUCTURE
US4366162A (en) Aryl ethers of N-alkyl-piperidines and acid addition salts thereof
US4857536A (en) Antihistaminic benzimidazole derivatives
JPH0780888B2 (ja) ピロロ〔１，２−ａ〕〔４，１〕ベンゾオキサゼピン誘導体
SK281980B6 (sk) Kryštallický (+)l-hydrogenvínan, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom a jeho použitie
US5633255A (en) 1,2-dihydro-2-oxo-3-aminoquinoxaline derivatives, their preparation and their therapeutic application
JPH0517443A (ja) ピペリジン誘導体
JPH03294277A (ja) ピペリジン誘導体
JPH0525140A (ja) ベンズイミダゾール誘導体
NZ247748A (en) Thiosemicarbazonic acid ester derivatives, preparation and pharmaceutical compositions thereof